| |
| |
|
| Insider
Information: |
Gerst Diane G. |
| Relationship: |
Director |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
15,558 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$664,949 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
15,558 |
|
|
| Total
Value |
$664,949 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
Director |
2023-06-05 |
15,558 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
Corp. SVP of Quality Assurance |
• – – |
2015-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,688 |
19,496 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
Corp. SVP of Quality Assurance |
• – – |
2015-04-08 |
4 |
OE |
$14.80 |
$148,000 |
D/D |
10,000 |
29,496 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
Corp. SVP of Quality Assurance |
• – – |
2015-04-08 |
4 |
AS |
$15.79 |
$157,900 |
D/D |
(10,000) |
19,496 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2015-04-14 |
4 |
D |
$15.22 |
$13,120 |
D/D |
(862) |
18,634 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2015-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,544 |
20,178 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
11,253 |
32,858 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-03-26 |
4 |
D |
$11.96 |
$7,343 |
D/D |
(614) |
32,244 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-04-14 |
4 |
D |
$12.66 |
$9,381 |
D/D |
(741) |
31,503 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-04-18 |
4 |
OE |
$10.48 |
$154,501 |
D/D |
14,210 |
45,713 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-04-18 |
4 |
AS |
$12.83 |
$200,649 |
D/D |
(15,637) |
30,076 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-04-19 |
4 |
AS |
$13.04 |
$73,125 |
D/D |
(5,607) |
30,076 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-04-19 |
4 |
OE |
$10.48 |
$58,761 |
D/D |
5,607 |
35,683 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-05-18 |
4 |
S |
$13.97 |
$19,939 |
D/D |
(1,427) |
28,649 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-06-15 |
4 |
D |
$15.76 |
$2,301 |
D/D |
(146) |
28,985 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-08-19 |
4 |
OE |
$10.93 |
$295,975 |
D/D |
24,046 |
53,031 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-08-19 |
4 |
AS |
$19.28 |
$463,607 |
D/D |
(24,046) |
28,985 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2016-12-15 |
4 |
S |
$20.51 |
$60,287 |
D/D |
(2,940) |
26,195 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,861 |
37,056 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2017-03-17 |
4 |
D |
$13.75 |
$16,418 |
D/D |
(1,194) |
35,862 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2017-03-26 |
4 |
D |
$13.76 |
$8,449 |
D/D |
(614) |
35,248 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2017-04-14 |
4 |
D |
$14.80 |
$11,159 |
D/D |
(754) |
34,494 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2017-06-15 |
4 |
D |
$16.18 |
$2,362 |
D/D |
(146) |
34,348 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2017-10-05 |
4 |
OE |
$11.33 |
$95,671 |
D/D |
8,444 |
42,792 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2017-10-05 |
4 |
AS |
$18.87 |
$159,376 |
D/D |
(8,444) |
34,348 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
EVP, QA & Regulatory Affairs |
• – – |
2017-10-17 |
4 |
AS |
$18.48 |
$9,665 |
D/D |
(523) |
33,825 |
0 |
- |
|
45 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
